Factors affecting drug concentrations and QT interval during thioridazine therapy. [electronic resource]
- Clinical pharmacology and therapeutics Nov 2007
- 555-65 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-6535
10.1038/sj.clpt.6100195 doi
Adult Age Factors Aged Aged, 80 and over Alleles Antipsychotic Agents--administration & dosage Aryl Hydrocarbon Hydroxylases--genetics Cross-Sectional Studies Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2D6--genetics Dopamine Antagonists--adverse effects Female Genetic Variation Genotype Heart Conduction System--drug effects Humans Linear Models Long QT Syndrome--blood Male Mesoridazine--adverse effects Middle Aged Mixed Function Oxygenases--genetics Risk Factors Schizophrenia--drug therapy Sex Factors Smoking--adverse effects Thioridazine--administration & dosage White People--genetics